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Validation of the Chinese version of the CogState computerised
cognitive assessment battery in Taiwanese patients with heart failure
Cheng-Chen Chou, Susan J Pressler, Bruno Giordani and Susan Jane Fetzer
Aims and objectives. To evaluate the validity of the Chinese version of the CogState
battery, a computerised cognitive testing among patients with heart failure in Taiwan.
Background. Cognitive deficits are common in patients with heart failure and a
validated Chinese measurement is required for assessing cognitive change for this
population. The CogState computerised battery is a measurement of cognitive
function and has been validated in many languages, but not Chinese.
Design. A cross-sectional study.
Methods. A convenience sample consisted of 76 women with heart failure and 64
healthy women in northern Taiwan. Women completed the Chinese version of the Cog-
State battery and the Montreal Cognitive Assessment. Construct validity of the Chinese
version of the battery was evaluated by exploratory factor analysis and known-group
comparisons. Convergent validity of the CogState tasks was examined by Pearson cor-
relation coefficients.
Results. Principal components factor analysis with promax rotation showed two
factors reflecting the speed and memory dimensions of the tests. Scores for CogState
battery tasks showed significant differences between the heart failure and healthy
control group. Examination of convergent validity of the CogState found a signifi-
cant association with the Montreal Cognitive Assessment.
Conclusion. The Chinese CogState Battery has satisfactory construct and conver-
gent validity to measure cognitive deficits in patients with heart failure in Taiwan.
Relevance to clinical practice. The Chinese CogState battery is a valid instrument
for detecting cognitive deficits that may be subtle in the early stages, and identify-
ing changes that provide insights into patients’ abilities to implement treatment
accurately and consistently. Better interventions tailored to the needs of the cogni-
tive impaired population can be developed.
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What does this paper contribute
to the wider global clinical
community?
• The validity of the Chinese ver-
sion of the CogState computer-
ised cognitive testing battery
among Taiwanese people with
heart failure were confirmed.
• Providing a useful and standar-
dised measurement for assessing
cognitive function in Chinese-
speaking people with heart fail-
ure.
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Introduction
Heart failure (HF) is a major and growing problem world-
wide and is associated with significant mortality and frequent
hospitalisations (Gwadry-Sridhar et al. 2004). Cognitive def-
icits are common in patients with HF; prevalence ranges from
25–50% among this population (Vogels et al. 2007, Pressler
2008). One of the most likely aetiologies of cognitive decline
in HF is inadequate cerebral perfusion and cerebral hypoxia
caused by low cardiac output (Bennett et al. (2005); Pullicino
& Hart 2001). Studies report that HF patients are at four
times increased risk for cognitive deficits compared with
matched controls (Sauve et al. 2009). Qiu et al. (2006) have
demonstrated that people with HF have twice the risk of
dementia and Alzheimer disease over nine years.
Compared to healthy persons, patients with HF have
shown cognitive deficits in areas including attention and
concentration, memory, psychomotor speed and executive
function (Bennett et al. 2005). Complaints of memory
impairment are among the most frequently reported cogni-
tive deficits in HF patients, affecting approximately 40% of
them (Sauve et al. 2009, Pressler et al. 2010b, Hawkins
et al. 2012). Evidence supports that HF is associated with
changes in brain structures which are critical for memory
functioning. For example, HF patients had grey matter loss
in brain areas involving cognition, including the prefrontal
cortex areas critical to working memory (Woo et al. 2003).
Brain injuries emerged in several areas in HF patients,
including the hippocampus, fornix, thalamus, mammillary
body and fornix fibres (Kumar et al. 2009, Woo et al.
2009), which serve important roles in episodic memory.
Empirical studies have consistently demonstrated the sig-
nificant impacts of cognitive function on daily activities,
HF self-care and mortality. For example, researchers
reported verbal memory has been found to successfully
explain performing instrumental activities of daily living
(Hammers et al. 2013). The deficits in cognitive function
may result in forgetfulness and poor learning ability that
lead to failure to adhere to treatment regimens (Dickson
et al. 2007). In a study among 166 HF patients, cognitive
deficits predicted 12-month mortality (Pressler et al.
2010a). Although cognitive deficits have consistently been
reported by patients who suffer from HF, there are no gen-
erally accepted measures for cognitive screening in them.
Background
The CogState battery is a standardised, computerised cogni-
tive test battery that was developed to measure cognitive
function (Fredrickson et al. 2010). This test battery was
selected because of its brevity, good usability, culture-free
stimuli (i.e. playing cards). The general CogState battery is
comprised of subset tasks to assess psychomotor speed, atten-
tion, working memory, visual and verbal memory, executive
function and social cognition (Maruff et al. 2009). The bat-
tery has demonstrated sound psychometric properties. Test-
retest reliability has been shown to be satisfactory, with six
days test-retest correlations in patients with coronary surgery
ranging from 061–092. In a recent study, of HF patients in
English, eight-week test–retest correlations ranged from
053–068 among 17 HF patients (Hammers et al. 2013).
Validity has been demonstrated between CogState tests and
traditional neuropsychological measures with most of the
correlations moderate to large (De Jager et al. 2009, Pietrzak
et al. 2009, Yoshida et al. 2011). The CogState test battery
significantly differentiates cognitive performance between
persons with schizophrenia (n = 121) and matched partici-
pants in the control groups (n = 120) (Pietrzak et al. 2009).
Stability is acceptable, with intra-class correlation coeffi-
cients over 12 months ranging from 065–091 in older
adults (Fredrickson et al. 2010). The battery identifies mild
cognitive impairment with good sensitivity (78%) and speci-
ficity (90%) among older adults (De Jager et al. 2009).
Evidence has shown that subsets of the CogState tasks
are sensitive to cognitive changes in groups such as those
with schizophrenia (Maruff et al. 2009, Pietrzak et al.
2009), mild traumatic brain injury (Maruff et al. 2009),
dementia or Alzheimer’s disease (Maruff et al. 2009, Ham-
mers et al. 2012, Lim et al. 2012a), and mild cognitive
impairment (Darby et al. 2002, De Jager et al. 2009).
However, only one study with a small sample size evalu-
ated the utility of the CogState verbal memory subset in an
HF population (Hammers et al. 2013).
Given the high prevalence and importance of cognitive defi-
cits in HF, the routine use of validated and brief, but sensitive,
assessment instruments is needed for early detection of mem-
ory impairment in this population. The English CogState com-
puterised battery has been translated in French, Korean (Lim
et al. 2012b) and Japanese (Yoshida et al. 2011). The valida-
tion of the CogState tasks in a Chinese population has not yet
been examined. Therefore, the purpose of this study was to
evaluate the validity of the Chinese version of the CogState
tests in Taiwanese patients with heart failure.
Methods
Design
A cross-sectional design recruited a convenience sample of
76 women with chronic HF and 64 age- and education-
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matched healthy women. The demographic and clinical
information, the Montreal Cognitive Assessment (MoCA)
and the Chinese computerised CogState battery were used
to collect data through interview and medical records.
Setting and participants
The study was conducted in northern Taiwan during
November 2010 through October 2011. Women were eligi-
ble if they were age 50 years and older, their last menstrual
cycle was completed more than 12 months previously, and
could read and speak Mandarin, with HF had the diagnosis
at least six months while healthy women, no major medical
diagnoses. Exclusion criteria included any conditions
known to cause cognitive deficits or the presence of
impaired sensory problems. Women with hypertension and
a blood pressure <140/90 mmHg or hyperlipidemia with
cholesterol less than 200 mg/dl were placed in the healthy
group.
Measures
Demographic and clinical information
This questionnaire was design to collect demographic and
HF information of the participants, including data of age,
education, marital status, employment, oestrogen replace-
ment therapy, comorbidity number, blood pressure and
NYHA functional class.
CogState Computerised Cognitive Assessment Battery
The tasks in the Chinese version of CogState battery were
translated from the English version into Chinese and made
available by CogState Company (http://cogstate.com/) using
a linguistically validated process to produce an instrument
that is conceptually equivalent to the English version. The
CogState validation process included seven steps: concep-
tual definition, forward translation, backward translation,
pilot testing, international harmonisation, proofreading and
reporting (MAPI Institute, 2011). Six tasks of the CogState
were selected for validation.
Two CogState tasks measuring psychomotor speed and
attention were evaluated. The Detection task (DET) is a
psychomotor speed task that requires participants to
respond as soon as possible when a playing card in the cen-
tre of the computer screen flips over. The Identification task
(IDN) is a measure of visual attention that assesses speed of
performance. Participants are asked to press the ‘yes’ but-
ton as soon as possible if the card in the centre of the
computer screen is red and the ‘no’ button if the card is
black (Collie et al. 2007). The task ends when 30 correct
trials have been completed. A lower score indicated better
performance.
Working memory was measured by The One Back Task
(OBK). The OBK is a measure of working memory that
assesses accuracy of performance. The participant presses
the ‘yes’ button if a playing card is the same as the immedi-
ately previous card and the ‘no’ button if the card is differ-
ent (Cysique et al. 2006). Thirty correct trials are required
for completion. A higher score indicates better perfor-
mance.
Verbal memory was measured by International Shopping
List Task (ISLT), which included 3 trials of immediate free
recall of a series of 12-word lists, followed by 20-minute
delayed recall of the word list. The individuals are required
to remember a list of shopping items that are relevant to
their culture. Studies have reported that performance is
equivalent among English, French and Malaysian versions
of the ISLT (Lim et al. 2009). The ISLT has been shown to
correlate with the Hopkins Verbal Learning Test-Revised
(HVLT–R) (r = 047 to 075) and had adequate stability in
patients with chronic HF (r = 053 to 068) (Hammers
et al. 2013). Possible scores range from 0–36 in the ISLT
first three trials and 0–12 in the delay recall ISLT. A higher
score indicates better verbal memory performance.
Visual memory was measured by the One Card Learning
Task (OCL) and the Continuous Paired Associate Learning
Task (CPAL). The OCL assesses accuracy of performance.
Similar in presentation to the OBK, the participants press
the ‘yes’ button if the card has appeared before or the ‘no’
button if it has not appeared. The OCL ends after 42 trials
are completed (Fredrickson et al. 2010). A higher score
indicates a better performance. The CPAL requires partici-
pants to learn sets of pattern–location associations in acqui-
sition and learning phases. In the first phase, the participant
is asked to remember the identical shape patterns hidden
beneath peripheral locations. In the learning phase, each
pattern is presented in the centre of the screen and the par-
ticipant is required to select the correct pattern presented in
the peripheral location (O’Donnell et al. 2011). It is scored
as the total number of errors across seven rounds, with
lower scores indicating better visual memory performance.
Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) was used to
measure global cognitive function and test construct valid-
ity of the CogState. It was developed by Nasreddine et al.
(2005) as a screening tool for mild cognitive impairment
(MCI) and early dementia. The MoCA is a 10-minute test
and includes items on visual spatial abilities, naming, short-
term memory recall, attention, language, verbal abstraction,
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memory and orientation. The MoCA was selected as a
measure of global cognitive function because it has been
demonstrated to be more sensitive in detecting cognitive
impairment in HF patients than another commonly used
instrument, the Mini-Mental Status Examination (MMSE)
(Athilingam et al. 2011). Possible MoCA scores range from
0–30; higher scores indicate better global cognitive func-
tion. Using a cut-off score of 26 to identify MCI, a sensitiv-
ity of 90% and a specificity of 87% were found among 93
patients with mild Alzheimer’s disease (AD) and 90 healthy
older controls in the original study in Canada (Nasreddine
et al. 2005). The criterion validity, internal consistency and
test-retest reliability were satisfactory in the Chinese version
of MoCA (Wong et al. 2009).
Data collection and procedures
After obtaining approval from the Institutional Review
Board of the University of Michigan, and the Tri-Service
General Hospital in Taipei, Taiwan, the investigator
approached potential participants at the cardiovascular,
gynaecology and women’s health centre clinics who met
inclusion criteria. Written informed consent was obtained
and data were collected by face-to-face interviews. Data
collection required 60–90 minutes. Demographic and clini-
cal information was collected using questionnaires and
from the medical record. The MoCA and the computerised
CogState tests were administered by the researcher who
had been trained by a neuropsychologist.
Statistical Analysis
Using SPSS version 17.0 software (Statistical Package for
Social Sciences, Inc., Chicago, IL, USA), descriptive statis-
tics were used to summarise demographic and clinical vari-
ables, scores for CogState computerised tasks and MoCA
results. Student’s t-tests, chi-square tests and Fisher’s exact
tests were used to examine differences between groups.
The factor structure of the CogState tasks was determined
by performing exploratory factor analysis using principal
components analysis with varimax rotation. The Kaiser–
Meyer–Olkin (KMO) test and Bartlett’s test of sphericity
were used to examine sampling adequacy and model appro-
priateness for performing factor analyses. Criteria used for
factor extraction included having eigenvalues greater than 1,
factor loadings higher than 030 and interpretability (Field
2005). Analysis of covariance (ANCOVA) was used for each
subset of the CogState battery (DET, IDN, ONB, ISLT,
ISLT-DR, OCL and CPAL) to compare differences in means
adjusting for age and education between the HF and healthy
group. Convergent validity was examined by calculating
Pearson correlation coefficients for CogState tasks (DET,
IDN, ONB, ISLT, ISLT-DR, OCL and CPAL) and the
MoCA.
Results
Sample characteristics
The sample included 76 women with HF and 64 healthy
women. In HF group, the mean age of the subjects was
697 years (SD = 102) (Table 1). The education matched
educational level was 73 years (SD = 33). The majority
of participants were married (803%) and were not
employed (921%). Women with HF had significantly
higher systolic blood pressures and more comorbid diseases
compared to healthy women. Moreover, most women with
HF were in New York Heart Association (NYHA) class II
(75%).
Exploratory factor analysis
Exploratory factor analysis using principal components
analysis was performed to determine the number and the
content of factors underlying the CogState tasks. The Kai-
ser–Meyer–Olkin test measure for the data was 0724, indi-
cating sampling adequacy and compact patterns of
correlation; the factor analysis produced distinct and reli-
able factors (Field 2005). Bartlett’s test of sphericity
reached statistical significance (p < 0001), which supported
that relationships between the variables existed (Field
2005). Oblique promax rotations were applied as the Cog-
State factors were assumed to be correlated. Factor analysis
showed the presence of two factors with eigenvalues >1,
explaining 646% of the total variance (Table 2). The first
factor accounted for 4495% of the total variance and con-
tained OBK, ISLT, ISLT-DR, OCL, and CPAL and was
labelled ‘memory’, with factor loadings ranging 061–081.
The second factor accounted for 1969% of the total vari-
ances and contained two-subset tasks (DET and IDN) and
was labelled ‘speed’. Factor loadings ranged from 090–
091.
Construct validity
A group comparison analysis was conducted to see how
well CogState tasks discriminated among the two groups of
women who differed in terms of their HF diagnosis
(Table 3). The ANCOVA resulted in statistically significant
differences (p < 005) for CogState scores between the HF
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and healthy groups. Women with HF reported higher psy-
chomotor speed score than did healthy women (DET,
p < 001) and lower scores on working memory (OBK,
p < 005) and verbal memory tasks (ISLT, p < 0001; ISLT-
DR, p < 0001), after controlling for age and education
years, providing evidence that further supported the con-
struct validity of the CogState battery.
Convergent validity
The relationship between each individual test score of the
CogState and MoCA are presented in Table 4. Significant
correlations were also shown between the MoCA scores are
subset tasks of the CogState. These findings demonstrate
convergent validity of the CogState.
Discussion
This is the first study to report use of the Chinese version
of a computerised cognitive test battery in an HF popula-
tion. Results supported the hypothesis that the Chinese
CogState subtests demonstrated good construct validity and
convergent validity among Taiwanese HF patients.
Findings of the exploratory factor analysis pointed to the
common features of the selected CogState battery tasks,
namely speed and memory, which support construct valid-
ity of the selected CogState battery items in this population.
The OBK, OCL and CPAL present visual stimuli in the cen-
tre of the computer, and participants must memorise pre-
sentations to perform adequately. The ISLT, on the other
hand, provides verbal stimuli that participants need to
recall immediately or later and performance is based on
how many words can be recalled correctly. For the remain-
ing measures, such as DET and IDN, although the visual
stimuli are presented in the middle of the computer screen,
the participants are required to respond as quickly as possi-
ble. Four tasks loaded on the factor labelled as memory,
Table 1 Demographic information of sample
Characteristics HF (n = 76) Health (n = 64) p-Value
Age, mean  SD 697  102 689  71 059
Marital status, n (%)
Married 61 (803) 41 (641) 016
Single 1 (13) 2 (30)
Divorced 2 (26) 4 (63)
Widowed 12 (158) 17 (266)
Education, mean  SD 73  33 80  31 019
Employment, n (%)
No 70 (921) 45 (703) 0001**
Yes 6 (79) 19 (297)
Systolic blood pressure, mean  SD 1355  175 1223  95 <0001***
Diastolic blood pressure, mean  SD 761  102 744  69 027
Comorbidity number, mean  SD 18  09 02  04 <0001***
NYHA class, n (%)
Class I 6 (79)
Class II 57 (75)
Class III 11 (145)
Class IV 2 (26)
HF, heart failure; NYHA, New York Heart Association
*p < 005, **p < 001, ***p < 0001.
Table 2 Principal components analysis of CogState tests in the HF
group (n = 76)
Factor loadings
Factor 1 Factor 2
Factor 1: Memory
One Back, accuracy (OBK) 081 008
International Shopping List, total (ISLT) 071 027
International Shopping List,
delayed recall (ISLT-DR)
077 024
One Card Learning, accuracy (OCL) 074 039
Continuous Paired Associate
Learning, error (CPAL)
061 007
Factor 2: Speed
Detection task 003 090
Identification task 005 091
Eigenvalue 315 138
Explained variance 4495 1969
Cumulative variance 4495 6464
Total CogState tests
HF, heart failure; Kaiser–Meyer–Olkin (KMO) test measure of
sampling adequacy = 0724; Bartlett’s test of sphericity p < 0001.
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which included working memory (OBK) and episodic mem-
ory tasks (OCL, ISLT and CPAL). The findings are similar
to those of Yoshida et al. (2011), who conducted a factor
analysis for the CogState Schizophrenia Battery in 40 Japa-
nese patients. In our study, however, OBK was included in
the memory factor, while Yoshida et al. (2011) found the
OBK was not associated with any factor solution. The
small sample size of the Japanese study (n = 40) may
explain the findings.
Results showed that HF patients scored significantly
lower than the healthy controls group, which is consistent
with previous findings using other standard neuropsycho-
logical tests (Sauve et al. 2009, Pressler et al. 2010b).
Women who have HF are more likely to demonstrate poor
performance on most of the CogState memory tasks when
compared to a healthy female control group. Although
CPAL task results were not significantly different in the
two groups, the HF group had more CPAL errors com-
pared to the control group. These results are congruent
with findings that HF patients show increased injury in
brain regions associated with the working memory system
(Woo et al. 2003) as well as in brain regions associated
with episodic memory (Kumar et al. 2009, Woo et al.
2009).
The Chinese CogState subtests were significantly corre-
lated with MoCA is the Chinese sample. The MoCA evalu-
ates different cognitive abilities, including memory
(Nasreddine et al. 2005), thus these results provided evidence
that supports validity of the Chinese CogState subtests. The
English version of the selected CogState tests (DET, IDN,
OBK, ISLT) was significantly correlated with standard neuro-
psychological tests and only ISLT was significantly correlated
with MMSE in a small HF sample (n = 40) (Hammers et al.
2013). Interesting, no association was found between the glo-
bal cognitive measure (MMSE or MoCA) with DET or IDN
in this current study or previous HF study (Hammers et al.
2013). This finding may be explained as the DET and IDN
are measures of psychomotor speed and the MMSE or
MoCA did not measure any speed of response. The current
study found that memory subtests such as OBK, ISLT, OCL
and CPAL had significant correlations with a global cognitive
measure (MoCA). Compared to MMSE, the MoCA is a sen-
sitive cognitive screening measure that can identify possible
MCI in patients with HF (Cameron et al. 2012). Future study
is needed to compare correlations among the Chinese Cog-
State subtests using standard neuropsychological tests in the
HF population.
There are some limitations of the study. Although the study
did not evaluate test-retest reliability of the Chinese CogState,
other studies have reported acceptable test-retest reliability
for its subtests in non-Chinese older adults (Fredrickson et al.
2010). Future study is needed to evaluate test–retest reliability
of the Chinese CogState. In addition, some participants with
less computer experience required more time and practice
before they feel comfortable to complete the tasks. Use of a
Table 3 Group comparison for CogState subset tasks
HF (n = 76)
mean  SD
Health (n = 64)
mean  SD F p
Detection, speed 27  01 26  01 76 0007**
Identification, speed 27  01 27  00 02 065
One Back, accuracy 10  02 11  01 43 004*
International Shopping List, total 202  57 234  44 147 <0001***
International Shopping List, delayed recall 68  28 83  19 139 <0001***
One Card Learning, accuracy 09  01 09  01 36 006
Continuous Paired Associate Learning, error 967  613 793  403 28 010
HF, heart failure.
p-Value for analysis covariance adjusting for age and education.
*p < 005 **p < 001 ***p < 0001.
Table 4 Pearson’s product-moment correlations between CogState
tests and MoCA
CogState Tests
MoCA
HF group
Healthy
group Totals
Detection task 0186 0017 0208*
Identification task 0208 0115 0191*
One Back task 0417*** 0526*** 0472***
International
Shopping List Task
0565*** 0582*** 0610***
International Shopping
List Task: delayed recall
0640*** 0647*** 0676***
One Card Learning Test 0395*** 0330** 0404***
Continuous Paired
Associate Learning Task
0396** 0408** 0421***
MoCA, Montreal Cognitive Assessment; HF, heart failure.
*p < 005, **p < 001, ***p < 0001.
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laptop with a touch screen is suggested for future studies.
Another limitation is that participants included only women
with HF. It is not clear whether these results would be the
same for men or for other chronic diseases.
Conclusion
This study demonstrated that the Chinese CogState Com-
puterized Cognitive Assessment Battery has satisfactory
construct and convergent validity to measure cognitive defi-
cits in patients with HF in Taiwan. We recommend the
Chinese CogState subtests to be compared to more standard
neuropsychological tests.
Relevance to clinical practice
As clinicians have a better understanding of cognitive deficit
patterns in patients with HF and other chronic diseases is
important that they provide improved care and treatment.
Nurses play a critical role in assisting patients to plan long-
term treatments towards the goal of successful living. The
CogState battery could be used to help detect cognitive defi-
cits that may be subtle in the early stages, and identify
changes that provide insights into patients’ abilities to
implement treatment accurately and consistently. Better
interventions tailored to the needs of the cognitive impaired
population can be developed.
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